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Abstract
Age-related muscle wasting (sarcopenia) is accompanied by a loss of strength which can compromise the
functional abilities of the elderly. Muscle proteins are in a dynamic equilibrium between their respective rates of
synthesis and breakdown. It has been suggested that age-related sarcopenia is due to: i) elevated basal-fasted rates
of muscle protein breakdown, ii) a reduction in basal muscle protein synthesis (MPS), or iii) a combination of the
two factors. However, basal rates of muscle protein synthesis and breakdown are unchanged with advancing
healthy age. Instead, it appears that the muscles of the elderly are resistant to normally robust anabolic stimuli
such as amino acids and resistance exercise. Ageing muscle is less sensitive to lower doses of amino acids than the
young and may require higher quantities of protein to acutely stimulate equivalent muscle protein synthesis above
rest and accrue muscle proteins. With regard to dietary protein recommendations, emerging evidence suggests
that the elderly may need to distribute protein intake evenly throughout the day, so as to promote an optimal per
meal stimulation of MPS. The branched-chain amino acid leucine is thought to play a central role in mediating
mRNA translation for MPS, and the elderly should ensure sufficient leucine is provided with dietary protein intake.
With regards to physical activity, lower, than previously realized, intensity high-volume resistance exercise can
stimulate a robust muscle protein synthetic response similar to traditional high-intensity low volume training,
which may be beneficial for older adults. Resistance exercise combined with amino acid ingestion elicits the
greatest anabolic response and may assist elderly in producing a ‘youthful’ muscle protein synthetic response
provided sufficient protein is ingested following exercise.
Introduction
Demographics indicate that the world’s population aged
60 years and over will more than triple within 50 years
from 600 million in the year 2000, to more than 2 bil-
lion by 2050 [1]. As a result of this the fastest growing
sub-population of society, in the developed world, is
adults aged ≥ 80 [1]. This presents issues for health care
for which we may well be ill-prepared. For example,
aging is accompanied by numerous increasingly preva-
lent clinical conditions such as rheumatoid- and osteo-
arthritis, vascular disease, Type II diabetes, and osteo-
porosis that require extensive health care resources,
which can lessen the quality of life, and reduce indepen-
dence [2].
Contributing to the risk of these diseases or as a direct
predictor of disability itself, is the slow and inevitable
age-related decline in skeletal muscle mass, referred to
as sarcopenia [2]. Age related sarcopenia, particularly of
type II muscle fibres, is accompanied by a decline in
strength which has consequences for physical mobility/
function and is associated with a greater incidence of
falls in the elderly [2-4]. Although we will all lose mus-
cle mass as we age, individual differences in: i) the rate
of loss in muscle mass, ii) the age at which muscle mass
starts to decline, and iii) an individual’s peak muscle
mass, determine the impact sarcopenia has on func-
tional ability. Age-related sarcopenia begins in our 4-5
th
decade and proceeds at ~0.6% annually thereafter [5].
Such a rate of sarcopenic muscle mass loss would not
likely have overly dire consequences; however, during
periods of muscle disuse/unloading that occur with
increasing frequency in the elderly, for example, due to
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loss is exacerbated [6]. Following such periods of disuse,
even something as benign as a reduction in daily step
counts [6], can accelerate sarcopenic muscle loss, from
which it is more difficult for the elderly to recover [7].
Thus, there is a clear need to improve our understand-
ing of the nature of age-related sarcopenia, in order to
develop non-pharmacological therapeutic interventions
to improve quality of life in the elderly.
A l t h o u g ht h ee t i o l o g yo fs a r c o p e n i ai sm u l t i f a c e t e d
[8], in the context of this review we will focus, primarily,
on the contribution of alterations in muscle protein
turnover (muscle protein synthesis and breakdown) to
muscle wasting in the elderly. Our understanding of the
contribution of muscle protein turnover to sarcopenia
has shifted from a thesis in which basal muscle protein
metabolism was thought to be compromised in the
elderly, to a new paradigm whereby the synthetic
responsiveness of muscle protein synthesis to anabolic
stimuli, such as food and contractile loading, is blunted
with aging. We draw on recent evidence to outline feed-
ing and exercise interventions that may maximize the
muscle protein synthetic response in elderly, possibly
even to a level typically found in younger adults, thereby
counteracting age-related sarcopenia.
Muscle protein metabolism in the elderly
Skeletal muscle proteins are constantly and simulta-
neously synthesized and degraded. Net protein balance
is defined as the difference between skeletal muscle
protein synthesis (MPS) and breakdown (MPB). Thus,
a significant rise in MPS (anabolism) and/or a reduc-
tion in MPB (catabolism), such that net protein bal-
ance remains positive can result in the accretion of
skeletal muscle proteins. Conversely, a negative net
protein balance, arising from a reduction in MPS and/
or increase in MPB, will result in a loss of skeletal
muscle protein. Net protein balance is maintained by
ingestion of protein-containing meals which results in
systemic hyperaminoacidemia that is stimulatory for
the synthesis of new proteins [9-13]. Thus, in young
adults consuming adequate protein and energy who
are not performing exercise, skeletal muscle protein
mass remains relatively stable. However, the feeding-
stimulated rise in MPS is only transient and, even in
the face of available amino acids, returns to basal levels
[9,10]. In addition to protein consumption, exercise
increases rates of MPS, thereby improving net protein
balance [14-17]. The synergistic effect of protein inges-
tion with exercise potentiates the muscle synthetic
response, swinging net balance in favour of muscle
protein accretion [18,19], thereby permitting muscle
hypertrophy when practiced frequently over time
[20,21].
Early studies into the role of protein turnover in age-
related sarcopenia reported that muscle wasting in the
elderly was due to a decline in basal rates of MPS
[22-24], elevated basal rates of MPB [25], or a combina-
tion of the two processes resulting in a negative net pro-
tein balance. Evidence suggested that age-related
sarcopenia was the result of slower rates of basal, post-
a b s o r p t i v em y o f i b r i l l a rM P Sa n dam o r en e g a t i v en e t
protein balance in the elderly (aged >60), as compared
with young adults [22-24]. Specifically, reductions in the
resting fractional synthesis rates of muscle protein, on
the order of 20-30%, were reported in the elderly com-
pared with the young. In addition, others reported that
surrogate markers of myofibrillar proteolysis were ele-
vated by as much as 50% in the elderly as compared
with younger adults [25]. However, if there were a
simultaneous decline in resting basal FSR and an
increase myofibrillar breakdown, the rate of muscle
wasting would be greater than is typically observed (i.e.
0.5-1.5% per year between 50-80 years old [26]).
Furthermore, a general inconsistency of findings by
others to demonstrate reduced rates of MPS or mark-
edly elevated MPB in healthy older adults [27-29], have
led to the general agreement that basal skeletal muscle
net protein balance is not compromised with ageing
[27]. However, it is important to acknowledge that cur-
rent methods used to determine muscle protein turn-
over may not be sensitive enough to detect very small,
but potentially important, changes in muscle protein
metabolism the elderly. Alternatively, the discrepant
findings between these early studies with more recent
p a p e r sm a yh a v eb e e nd u et oafailure to distinguish
between healthy and frail elderly. Indeed, we postulate
that basal muscle protein metabolism may be compro-
mised in frail elderly, potentially due to greater systemic
inflammation and its associated co-morbidities [30,31],
or a reduction in physical activity compared with rela-
tively ‘well preserved’ elderly.
The inconsistent findings of earlier studies, combined
with evidence from older rats [32] and humans [33]
showing that protein requirements may be greater with
advancing age, led to the thesis that the elderly may be
less able to efficiently utilize amino acids for MPS. An
initial study demonstrated that basal rates of MPS were
similar in the elderly and young after oral ingestion of
amino acids [27]. However, the authors were unable to
identify a difference in the muscle protein synthetic
response to amino acids between elderly and young,
despite the fact that the splanchnic extraction of amino
acids was greater in the elderly (i.e. a reduction in
amino acids available for delivery to skeletal muscle).
However, it is possible that the muscle synthetic
response was saturated as amino acids were ingested in
repeated doses over several hours in this study [27]. In a
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with an amino acid-glucose mix, bypassing splanchnic
uptake, and demonstrated that rates of MPS increased
in the young but not the elderly [34], which was the
first demonstration of an ‘anabolic resistance’ of skeletal
MPS in the elderly. Several years later, Cuthbertson et
al. [29] were the first to compare the muscle synthetic
response to bolus oral doses of crystalline essential
amino acids (EAA) in the young and elderly. As
hypothesized, Cuthbertson showed that basal fasted
rates of MPS were indistinguishable between young and
old, but MPS in the elderly was less responsive to inges-
tion of crystalline EAA’s. The resistance of elderly mus-
cles to a physiological dose of amino acids was
subsequently confirmed by others [35-37] and is pre-
sented in Figure 1.
It is not known what causes anabolic resistance in
aging muscle. Two theses are that it could be a conse-
quence of the gradual decline in physical activity or an
age-related decline in processes related to inflammation,
which can interfere with protein turnover, although
which of these processes plays the more prominent role
in sarcopenia is difficult to answer. Given the detrimen-
tal effects of acute and chronic inflammation on skeletal
muscle mass and protein metabolism, age-associated
inflammation may affect the anabolic sensitivity of older
muscles. To date, the strongest evidence to this effect
has been generated from animal studies. For example,
sepsis has been shown to induce a dramatic muscle
mass loss associated with a reduction in protein synth-
esis rate in adult rats [38]. TNF-a,w h i c hi so n eo ft h e
main inducers of the acute-phase response [39], plays an
important role in alterations of muscle protein metabo-
lism in this model of sepsis [38]. Recently, others have
demonstrated that low-grade inflammation (LGI)
impairs the muscle protein synthetic response to feeding
in rats [40]. In humans, Toth et al. [31] have shown a
strong relationship exists between MPS and circulating
concentrations of several markers of immune activation.
At the mechanistic level, cytokines, in particularly TNF-
a, may impair MPS by blunting the phosphorylation of
proteins in the mammalian target of rapamycin (mTOR)
intracellular signalling pathway [41]; shown to be critical
for the regulation of mRNA translation and MPS for
muscle hypertrophy [42].
In addition to age-related phenomenon, there is no
doubt that physical inactivity per se has a detrimental
effect on rates of MPS. In young adults, a reduction in
physical activity through cast-induced immobilization of
the legs blunts basal and amino-acid stimulated rates of
MPS [43,44]. Thus, it is apparent that disuse induces
anabolic resistance in skeletal muscle. Recent work also
indicates that even short-term abrupt sedentarism, lead-
ing to a reduced relative loading of skeletal muscles,
results in loss of muscle mass in the legs [7]. In addi-
tion, the cellular mechanisms underpinning the resis-
tance of elderly muscles to amino acid provision are
becoming apparent, but are far from being completely
understood. Signalling proteins associated with the
mTOR pathway have consistently been shown to be sen-
sitized to amino acids [11,29]. Thus, diminished sensitiv-
ity of old muscles to anabolic stimuli may involve the
impaired phosphorylation of mTOR-mediated signalling
proteins. The amino acid-stimulated phosphorylation of
proteins in the mTOR pathway is relatively transient,
typically peaking between 1-2 h post-feeding [45] and
remaining elevated above basal until ~3-4 h post-feeding
[11,45]. Cuthbertson et al. [29] and Guillet et al. [46]
have shown previously that the phosphorylation of
mTOR and downstream targets implicated in translation
initiation; ribosomal protein S6 kinase (p70S6K) and
eukaryotic initiation factor 4E binding protein 1 (4E-
BP1), is dampened in elderly muscles in the presence of
amino acids as compared with the young. Thus, intra-
muscular signalling in the elderly may not be as sensi-
tive and/or responsive to amino acids as younger
muscles, and may explain the dampened MPS response
older adults; further studies are required to further sub-
stantiate such a thesis, however.
The notion of anabolic resistance in elderly muscles is
further supported by evidence that acute alterations in
MPS (i.e. 1-3 h) after a single bout of resistance exercise
[47,48] and endurance exercise [49], are impaired in the
elderly as compared with young men (Figure 1).
Furthermore, the hypertrophic response to a resistance
exercise programme may to be impaired with ageing
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Figure 1 Schematic representation of muscle protein
metabolism in response to anabolic stimuli (exercise and/or
amino acid ingestion) in young and elderly. We hypothesize the
primary reason for muscle loss in the healthy older adults is the
inability of elderly muscles to mount a robust ‘youthful’ protein
synthetic response to anabolic stimuli above that seen in the basal-
state. Shaded section indicates the difference in MPS between
elderly and young in response to anabolic stimuli.
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response is delayed until 3-6 h after exercise in the
elderly, whereas Kumar et al. [47] have shown that MPS
in the fasted state returns to basal values between 2-4 h
after exercise in both the young and elderly. The discre-
pancies between these studies may be due, in part, to
the higher volume of exercise used by Drummond et al.
[48] and the fact that these subjects were studied under
overnight fasted conditions. It has been demonstrated
that mTOR signalling is necessary to stimulate rates of
MPS after resistance exercise [51]. In combination with
lower rates of MPS in the elderly after acute resistance
exercise, Kumar et al. [47] showed that the phosphoryla-
tion of p70S6K and 4E-BP1 was blunted. The blunted
post-exercise anabolic signalling response in the elderly
was transient in nature (i.e. 1 h) and was not apparent 2
h after exercise [47]. Thus, older muscles are blunted in
their capacity to mount a robust ‘youthful’ muscle sig-
nalling and protein synthetic response to resistance
exercise. The main reason for this anabolically blunted
condition with age is not fully understood and may
require a greater contraction volume in older persons to
achieve a more robust response.
Protein-based interventions to counteract ‘anabolic
resistance’
The ingested protein dose and source dictates the
amplitude and duration of the rise in EAA’si nt h e
blood, which, in turn, affects the degree of MPS [52,53].
Considerations of protein quality have obvious impor-
tance, but this may be even more important when it
comes to the protein needs of older adults to maintain
their muscle mass. We have shown previously in young
adults that 5 g and 10 g of egg protein ingestion after
resistance exercise is sufficient to acutely increase MPS
above basal, a response that becomes saturated with 20
g of egg protein. Furthermore, we and others have
shown, in the context of resistance exercise in young
adults, that whey protein stimulates a greater acute (0-3
h post-exercise) rise in MPS compared with dose-
matched casein and soy proteins [52,53], and is still
highly effective at stimulating MPS over 3-5 h post-exer-
cise [54]. The mechanism underpinning the robust ana-
bolic properties of whey protein, relative to casein are
likely related to the more rapid digestion kinetics and
greater appearance of circulating amino acids [52,55], of
which, the branched-chain amino acid leucine may be
particularly important as a key metabolic regulator of
MPS through activation of the mTOR pathway [56,57].
The superior capacity of whey to stimulate MPS over
that of soy is not due to differing absorption kinetics
but likely to be a mere reflection of the lower leucine
content of soy versus whey protein. Thus, we are begin-
ning to understand the required dose and amino acid
source required to maximally stimulate MPS in the
young.
Data concerning the protein dose required to acutely
increase rates of MPS in the elderly are conflicting.
Using frequent small bolus feedings, Welle and Thorn-
ton [58] suggested that low (7% total energy), moderate
(14% total energy) and high protein (28% total energy)
meals stimulate rates of MPS to a similar extent.
Furthermore, the data of Cuthbertson et al. [29] showed
that anabolic resistance to crystalline EAA ingestion was
only apparent after 10-20 g doses, but as little as 2.5 g
of crystalline EAA was sufficient to increase myofibrillar
MPS above rest in both young and elderly. The data of
Cuthbertson et al [29] suggest that in anabolically resis-
tant elderly muscles a low dose of amino acids is suffi-
cient to stimulate MPS above rest but that the muscle is
refractory to a higher dose of EAA or protein [58].
Recent studies from our laboratory have led us to posit
that the elderly may require more protein to acutely
increase rates of MPS than the young. Specifically, we
constructed a dose-response curve of myofibrillar MPS
rates to graded doses of intact whey protein ingestion in
the elderly. In line with the findings of Cuthbertson
[29], we show that the basal rate of myofibrillar MPS in
the elderly plateaus after the ingestion of 20 g of whey
protein, containing ~10 g of EAA (Yang, Breen et al.
2011. Resistance exercise enhances myofibrillar protein
synthesis with graded intakes of whey protein in older
men, submitted). However, in contrast with the findings
of Cuthbertson [29] who showed as little as 2.5 g of
crystalline EAA increased MPS rates above rest, we
show that lowest dose of 10 g of whey, containing ~5 g
of EAA, did not elicit an anabolic response. Thus, we
now have preliminary evidence that MPS increases in
young muscles sharply after a meal containing low
doses of amino acids (5-20 g), and becomes saturated
after larger doses (20-40 g), whereas in the elderly the
muscle protein synthetic response is blunted in response
to low doses of amino acids (Figure 2).
The mechanism facilitating the impaired dose-
response of MPS to amino acids in the elderly compared
with the young is still elusive. However, we [59], and
others [60,61] have hypothesized the existence of a leu-
cine ‘threshold’ that must be surpassed after protein
ingestion to stimulate MPS above rest. This threshold is
not absolute and is graded with lower leucine stimulat-
ing responses in young persons, whereas the elderly
become less sensitive and the threshold becomes higher.
The leucine threshold hypothesis is based on a number
of recent observations [36,57,60-62], the most striking of
which is that leucine ingestion/infusion results in a
phosphorylation of proteins critical for the mTOR path-
way [57]. We postulate that young muscles are highly
sensitive to the anabolic actions of leucine as ~1 g of
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late MPS above rest [63]. In contrast, our recent obser-
vations indicate that the elderly are less sensitive to the
anabolic actions of leucine as ~2 g of leucine found in
20 g of whey protein was required to increase MPS
rates above rest (Yang, Breen et al. 2011. Resistance
exercise enhances myofibrillar protein synthesis with
graded intakes of whey protein in older men, sub-
mitted). Thus, we suggest that the greater leucinemia
associated with rapidly digested high leucine-content
proteins, may be crucial in order to facilitate a robust
muscle protein synthetic response in the elderly. Indeed,
the recent work of Pennings et al. [53] shows the greater
circulating concentrations of leucine after ingestion of
whey, compared with casein protein, was associated
with elevated rates of MPS. Furthermore, there was a
strong relationship between peak leucinemia and MPS
in this study [53]. Consistent with the thesis that leuci-
nemia is important in ‘driving’ MPS, the work of Katsa-
nos and colleagues [36] demonstrated that 6.7 g of EAA
(equivalent to ~15 g of whey), increased MPS above rest
in the elderly, but only after the leucine content of
EAA’s was increased from 26 to 41% (1.7 to 2.8 g). In
line with our hypothesis that younger muscles are more
anabolically sensitive, the 26% low-leucine treatment in
this study was sufficient to increase MPS in the young.
Thus, when considering protein feeding strategies that
will acutely increase MPS in the elderly, a protein
source with high leucine content and rapid digestion
kinetics, in order to promote a transient leucinemia
‘spike’ would be an effective option.
Despite the acute anabolic effects of leucine feeding,
the impact of chronic leucine supplementation on lean
mass maintenance/growth in the elderly is still unclear
due, in large part, to the limited number of studies. Sup-
plementation with leucine-rich amino acid mixtures has
been shown to improve strength and physical function
[64,65], and increase lean mass [66,67]. A recent study
by Verhoeven and colleagues [68] was the first, to our
knowledge, to investigate the long-term effects of free-
leucine supplementation (7.5 g·day
-1) in the elderly. The
authors showed no effect of leucine supplementation on
muscle mass or strength compared with a non-supple-
mented placebo group. One possibility is that free-leu-
cine simply ‘turns on’ mRNA translational processes,
but other essential amino acids are required to facilitate
the anabolic actions of leucine and promote hypertro-
phy. Another suggestion is that leucine supplementation
may need to be provided over a much longer period (i.e.
> 8 months) than has previously been studied [69].
Finally, given evidence in young adults that supplemen-
tation of leucine-rich high-quality proteins, such as
whey, augment exercise-induced lean mass and strength
gains to a greater extent than other protein sources
[20,70], free-leucine supplementation provided in the
context of a resistance exercise training programme may
promote muscle hypertrophy in the elderly. Most likely,
however, is that the rate of any potential leucine-
enhanced gains in feeding-induced MPS to augment
muscle mass are going to be too small for methods such
as DXA and biopsy to detect, even over a period of 6
months [71]. At this time it is not possible to defini-
tively conclude on the efficacy of leucine per se with or
without concurrent exercise training to counteract or
prevent sarcopenia.
In line with recent recommendations from Paddon-
Jones [72], we suggest that in order to elevate rates of
MPS and induce a net positive protein balance in resis-
tant elderly muscles, it may be important for older
adults to consume sufficient quantities of high-quality,
leucine-rich proteins to stimulate MPS. Thus, older
adults should distribute their daily protein equally across
three or more daily meals. For example, given our find-
ings that the elderly require more protein to increase
MPS above rest than the young, in a 75 kg individual
consuming ~60 g of protein daily (based on the RDA of
0.8 g·kg
-1), this would mean consuming ~20 g of protein
with each meal, as opposed to a typical feeding regimen
in which the elderly typically ingest smaller amounts of
Intact protein dose (g)
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Figure 2 Dose response curve of MPS in elderly and young
muscle with protein ingestion at rest. MPS in the young is
stimulated above basal with ~2.5 g of crystalline EAA (found in ~5
g of intact protein) before reaching a plateau at ~10 g of crystalline
EAA (found in ~20 g of intact protein). In the elderly, MPS is
increased above rest after ingestion of 20 g of whey protein and,
like younger adults, the response plateaus thereafter. Star indicates
MPS in both young and elderly after 6.7 g of EAA (typically found in
15 g of whey protein) enriched with leucine (41% or ~2.8 g) [36].
Finely dashed lines indicate the hypothesized leucine ‘threshold’
which must be surpassed in order to stimulate a robust increase in
rates of MPS. The threshold may be considerably lower in the
young (<1 g leucine in 2.5 g of crystalline EAA’s) compared with
the elderly (~1.5-2 g of leucine contained in 15-20 g of whey
protein).
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majority of dietary protein with dinner (~40 g) [73]. The
notion of equal daily protein distribution for the elderly
is based, partly, on a recent nitrogen balance study in
which Campbell and colleagues [74] showed that dietary
protein requirements are not different between young
and old and are similar to previous daily recommenda-
tions (~0.85 g·kg
-1·day
-1). It is important, however, to
note that slowly turning over pools of protein, such as
muscle, are captured in such measurements and
whether slow declines in MPS, and thus muscle size, are
too small to be captured in a short-term nitrogen bal-
ance study. For example, a 30% decline in resting (from
0.03%·h
-1 to 0.027%·h
-1 f o r1 0o f2 4hi nad a y )a n d
feeding-stimulated (from 0.06%·h
-1 to 0.042%·h
-1 for 14
of 24 h in a day) myofibrillar protein synthesis would
only result in a lower requirement for protein approxi-
mating 0.1 g protein·d
-1 (assuming a 70 kg male with 30
kg of muscle and that muscle is a homogeneous pool)
which is well within the error of the nitrogen balance
method.
Resistance exercise-based interventions to counteract
‘anabolic resistance’
Resistance exercise acutely increases MPS [22,29,48]
and, when practiced frequently over time, promotes
muscle hypertrophy in older adults [75-78], although
the anabolic response is generally blunted compared
with younger adults [47,79,80]. It has been suggested
these divergent responses to resistance exercise may be
due to the fact that the elderly generally lift a much
lower volume of weights than the young [47]. However,
we suggest that resistance to the anabolic nature of
hypertrophic exercise may be critical in mediating the
muscle adaptive remodelling in the elderly. To date,
only a small number of studies have sought to manipu-
late contractile activity in order to optimally stimulate
MPS and, in doing so, have uncovered interventions
with the potential to help elderly muscles overcome ana-
bolic resistance to exercise stimuli.
It has been shown that low-intensity resistance-exer-
cise (20-50% 1RM), coupled with blood flow occlusion
to the working muscle (using of an inflatable cuff),
induces hypertrophy and strength gains similar to those
found with high-intensity resistance exercise [81,82].
Specifically, Fry et al. [83] demonstrated that low-inten-
sity leg resistance exercise (4 sets of 15-30 reps at 20%
1RM) with blood flow restriction, increased mTOR sig-
nalling phosphorylation and MPS by ~56% above rest in
the elderly over 3 h post-exercise. Given that MPS in
e l d e r l ym u s c l ed o e sn o tr e s p o n dt ot r a d i t i o n a lh i g h -
intensity resistance exercise in the same manner as
young [47], low-intensity blood flow restriction resis-
tance exercise has been touted as an alternative, novel
rehabilitation therapy. Whether blood flow restriction
can be implemented effectively in exercise programmes
designed for the elderly remains to be seen. Taken
together with the knowledge that the elderly cannot
train as comfortably at the same relative high-intensity
as the young, these data beg the question; how low can
the resistance exercise intensity be and still produce a
physiological adaptation and functional benefit? In a
study by Fry et al. [83] it was shown that resistance
exercise at 20% 1RM, without blood restriction, was not
sufficient to increase rates of MPS above rest. A recent
publication from our laboratory [84], albeit in healthy
young adults, showed that low-load high volume leg
resistance exercise to failure (30% of 1RM) was more
effective at increasing MPS than high-load low volume
resistance exercise to failure (90% of 1RM). Specifically,
weight lifting at 30% of 1RM to failure induced similar
increases in MPS to that found after lifting 90% of 1RM
to failure at 4 h post-exercise [84]. This response was
sustained at 24 h only after the low-load high volume
exercise, which is in opposition to the commonly held
belief that one needs to lift heavier weights to induce
hypertrophy [85]. Thus, resistance exercise-induced
MPS may not necessarily be load-dependant but may
instead be determined by exercise volume; this would be
good news for older adults who may be unable to sus-
tain lifting weights at a relative high intensity due to sar-
copenic co-morbidities, such as osteoarthritis or other
connective tissue complications.
Previously, we have shown [76] that low-intensity
resistance exercise training (40% of 1RM), 3 times a
week for 12 weeks, increases leg strength, but not mus-
cle thickness in the elderly, suggestive of a neuromuscu-
lar adaptation. In contrast, high-intensity resistance
exercise (80% 1RM) in the elderly induced greater
strength gains than the low-intensity group, accompa-
nied by an increase in quadriceps muscle thickness [76].
Importantly, ~10 repetitions per set were performed by
both the low and high-intensity groups in this study
[76], thus the low-intensity group performed ~50% less
volume (repetitions x mass). Given these data, we sug-
gest that low-intensity resistance training be performed
to fatigue, which may result in a greater load than one
is able to perform with high-intensity training, in order
to promote equivalent gains in lean mass and strength
in the elderly [84]. This paradigm would require older
adults exercising at a low-intensity to complete a higher
number of repetitions, or weight lift to failure. The effi-
cacy of long-term low-load high-intensity training pro-
grammes for inducing hypertrophy in the elderly has yet
to be determined.
Finally, the synergistic anabolic effect of resistance
exercise in combination with essential amino acid inges-
tion has been well documented in the young
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publication, as little as 4.2 g of EAA (10 g of whey pro-
tein) can potentiate the exercise-induced rise in MPS in
healthy young adults [87]. Thus, there can be little
doubt that utilizing amino acid or protein feeding and
resistance exercise concurrently will promote an optimal
anabolic environment in elderly muscles compared with
either stimulus alone. Drummond et al. [48] demon-
strated that EAA ingestion after a bout of resistance
exercise increased rates of MPS to a similar extent in
young and elderly over 5 h post-exercise. In this study,
an acute (1-3 h post-exercise) MPS response was only
apparent in the young, but a delayed MPS response (3-5
h post-exercise) was greater in the elderly, suggesting
that the combination of EAA plus resistance exercise
may abolish anabolic resistance in the elderly via a
delayed stimulation of MPS. Previously, we have shown
that maximal post-exercise stimulation of MPS can be
achieved with ingestion of 20 g of egg protein in young
adults [63]. However, recent data from our laboratory
(Yang, Breen et al. 2011. Resistance exercise enhances
myofibrillar protein synthesis with graded intakes of
whey protein in older men’, submitted) suggest that
post-exercise rates of MPS increase in a stepwise man-
ner in response to graded doses of whey protein inges-
tion, the greatest increase apparent with 40 g of whey
(40 g > 20 g > 10 g). Thus, there is discordance between
this finding and our observation that, in the non-exer-
cised basal state, 20 g of whey protein maximally stimu-
lates rates of MPS. Thus, in the young, exercise-induced
rates of MPS plateau when 20 g of high-quality protein
is ingested, but in the elderly it appears that post-exer-
cise rates of myofibrillar MPS can be increased further
with ingestion of larger doses of protein. However, the
feasibility of instructing older adults to ingest 40 g of
protein in the post-exercise period is questionable.
Regarding the optimal timing of protein intake to
maximize resistance exercise-induced muscle protein
anabolism, there are few data available in the elderly
[90-92]. Human data intimate that mTOR mediated sig-
nalling and MPS may be suppressed during exercise, but
appear to rebound by ~60 min of recovery [91,93,94].
Thus, it has been suggested providing amino acids in
the post-exercise ‘window of opportunity’ may induce
the greatest anabolic response. However, studies have
failed to demonstrate an effect of manipulating the tim-
ing of protein ingestion (i.e. pre, peri or post-exercise)
on the acute synthetic response of muscle protein in the
young and elderly [88,89,91,95]. Interestingly, evidence
to the contrary exists in chronic training studies. For
example, in older adults, Esmark et al. [92] showed that
resistance training (over 12 weeks) followed by immedi-
ate ingestion of 10 g of protein resulted in greater gains
in muscle cross-section and isokinetic strength,
compared with a group who delayed protein intake until
2 h after each work-out. These data [92] are somewhat
puzzling as the gains in lean mass with immediate post-
exercise feeding were of similar magnitude to those
reported by others in the elderly with no specific feeding
intervention [50,77,78]. Thus, Esmarck et al. [92] did not
actually demonstrate any superior anabolic responses
with immediate ingestion of protein after resistance
training. Furthermore, these findings are not universal
as others [96] have failed to show similar long-term
benefits of immediate pre- and post-exercise protein
ingestion for muscle mass and strength in the elderly.
Recent evidence from our laboratory albeit in healthy,
young adults suggests that muscles remain sensitive to
protein ingestion at 24 h after low or high-intensity
resistance exercise performed to failure [97], as evi-
denced by an increase in mRNA translational signalling
and MPS. Thus, protein feeding during late exercise
recovery still maintains the capacity to be synergistic to
exercise-mediated rates that have been shown to exist in
the fasted-state during this time [14,98]. Whether this is
the case in older adults remains to be shown. The
notion that ingestion of amino acids immediately after
exercise is not critical for optimal stimulation of MPS is
supported by several studies [88,95,99]. Of these studies,
Tipton et al. [95] provide intriguing evidence that net
muscle protein synthesis is greater when an amino acid-
carbohydrate mixture is ingested prior to exercise, com-
pared with drink ingestion after exercise. Taken
together, these data give equivocal insight into the most
appropriate time to for older adults to consume protein
to optimize the resistance exercise-induced anabolic
response. It appears that protein ingestion at doses of at
least 20 g and perhaps as high 30-40 g, in close proxi-
mity to, and at intervals over 24 h after resistance exer-
cise, may be able to elicit an anabolic response in the
elderly.
Polyunsaturated fatty acids as an intervention to
counteract ‘anabolic resistance’
Fish-oil-derived omega-3 fatty acids (n-3 polyunsatu-
rated fatty acids) might be a potentially useful therapeu-
tic agent for the treatment and prevention of
sarcopenia. Initial studies in animals showed that sup-
plementation with omega-3 fatty acids increased the
phosphorylation of anabolic signalling proteins, whole-
body protein synthesis [100] and attenuated the loss of
muscle mass in burned animals [101]. In elderly
humans, Smith et al. [102] showed that 8-weeks of
omega-3 fatty acid supplementation augmented hyperin-
sulinemic-hyperaminoacidemic induced increases in
MPS and mTOR signalling, suggesting that omega-3
fatty acids attenuate age-related anabolic resistance.
Whilst the exact mechanisms by which omega-3 fatty
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elderly are not entirely clear, the anti-inflammatory
properties of omega-3 fatty acids [103] may be a critical
factor, particularly in the frail elderly who display ele-
vated levels of inflammation [30]. On the other hand,
recent evidence suggests that fatty acids may have
intrinsic muscle protein anabolic properties, as long-
chain n-3 polyunsaturated fatty acid supplementation
augments hyperinsulinemic-hyperaminoacidemic stimu-
lated muscle protein synthesis in healthy young subjects
[104], in whom inflammation would be expected to be
relatively low. Taken together, these data suggest that
fatty acid supplementation alone is insufficient to pro-
mote an anabolic response (as basal MPS is not
increased). Instead, additional stimuli, such as amino
acids, may be required to permit the anabolic effect of
fatty acids.
Non-steroidal anti-inflammatory drugs to restore
‘anabolic sensitivity’
The anabolic sensitivity of aged rat skeletal muscle can
be restored when LGI is controlled with the non-steroi-
dal anti-inflammatory drug (NSAID), ibuprofen [105]. In
older humans, training-induced gains in muscle mass
and strength appear to be greater in subjects supple-
mented with over-the-counter NSAID’s [106] compared
with non-supplemented elderly. The mechanism of
NSAID action appears to involve decreasing throughput
in the nuclear factor kappa B (NFB) pathway via
actions consequent to decreasing cyclooxygenase 2
(COX2) activity [105]. Pro-inflammatory cytokines
increase the synthesis of prostaglandin-E2 (PGE2) in
many cells types [107] by activation of COX2, a rate-
limiting enzyme in the synthesis of PGE2. A decrease of
PGE2 production has been shown to preserve MPS and
decrease MPB in skeletal muscle in highly inflamed rat
models [108,109]. To date, the paucity of human studies
makes it difficult to recommend a specific NSAID that
will effectively counteract low-grade inflammation
induced anabolic resistance. However, as highlighted by
Trappe et al. [106], there are many elderly who take
acetaminophen, ibuprofen and other non-prescription or
prescription COX inhibitors on a regular basis, thus, the
role of this class of drugs in skeletal muscle metabolism
needs to be further defined. At this time, the risks asso-
ciated with COX inhibitors [110,111] and the precise
mechanisms underpinning the response of skeletal mus-
cle to NSAID’s need to be considered before the recom-
mended use of these drugs in any population.
Summary
Ageing is associated with a blunted muscle protein syn-
thetic response to anabolic stimuli, i.e. feeding and resis-
tance exercise. However, dietary and exercise interventions
may prevent or slow sarcopenic muscle loss. First, we
stress the importance of ingesting sufficient protein with
each meal for older adults. Specifically, given the blunted
sensitivity of older muscles to low doses of amino acids, a
dietary plan that includes at least 20 g and as high as 30
g of high quality protein per meal will provide sufficient
essential amino acids, particularly leucine, required to eli-
cit a robust acute muscle protein synthetic response
above that seen at rest, thereby promoting the accretion
of muscle protein over time. Secondly, we advise the use
of resistance exercise in the elderly to induce hypertrophy,
improve strength and improve physical function. In older
adults who are not restricted by physical disability, fre-
quent high-intensity weight lifting will increase lean mus-
cle mass. Alternatively, low-intensity high volume weight
lifting may also promote an adaptive response in the
elderly provided the working muscle is sufficiently
‘stressed’ (i.e. via blood flow restriction to the muscle or
lifting to failure). Finally, utilizing resistance exercise and
protein ingestion concurrently will promote an optimal
anabolic response than either stimulus alone and should
be an important consideration for clinicians and patients
alike. However, in order to maximize the anabolic poten-
tial of prior resistance exercise, the elderly may require
more protein (~40 g) than the young (~20 g). Further
work is required in order to delineate the most appropri-
ate feeding strategies to augment resistance exercise adap-
tation in the elderly.
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